| 发明名称 |
COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR |
| 摘要 |
The present invention is directed to a combination therapy involving an anti-HER2 antibody-drug conjugate and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a HER2-expressing cancer. |
| 申请公布号 |
WO2017007846(A1) |
申请公布日期 |
2017.01.12 |
| 申请号 |
WO2016US41184 |
申请日期 |
2016.07.06 |
| 申请人 |
GENENTECH, INC.;F. HOFFMAN-LA ROCHE AG |
发明人 |
PHILLIPS, Gail Lewis;SAMPATH, Deepak;WERTZ, Ingrid |
| 分类号 |
C07K16/32;A61K39/395;G01N33/574 |
主分类号 |
C07K16/32 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
